Article Details
Retrieved on: 2021-03-01 04:18:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Strongbridge Biopharma plc. Somatostatin Receptor Type 4 Market Segmentation: Based on Type. CNTX-0290; NNC-26910; Veldoreotide. Based on ...
Article found on: www.nymarketreports.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here